950 related articles for article (PubMed ID: 17914397)
1. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers.
Binshtok AM; Bean BP; Woolf CJ
Nature; 2007 Oct; 449(7162):607-10. PubMed ID: 17914397
[TBL] [Abstract][Full Text] [Related]
2. Neuroscience: a local route to pain relief.
McCleskey EW
Nature; 2007 Oct; 449(7162):545-6. PubMed ID: 17914381
[No Abstract] [Full Text] [Related]
3. Emulsified isoflurane enhances thermal transient receptor potential vanilloid-1 channel activation-mediated sensory/nociceptive blockade by QX-314.
Zhou C; Liang P; Liu J; Zhang W; Liao D; Chen Y; Chen X; Li T
Anesthesiology; 2014 Aug; 121(2):280-9. PubMed ID: 24667830
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dental nociceptive neurons.
Kim HY; Chung G; Jo HJ; Kim YS; Bae YC; Jung SJ; Kim JS; Oh SB
J Dent Res; 2011 Jun; 90(6):771-6. PubMed ID: 21364091
[TBL] [Abstract][Full Text] [Related]
5. The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice.
Leffler A; Mönter B; Koltzenburg M
Neuroscience; 2006 May; 139(2):699-709. PubMed ID: 16515841
[TBL] [Abstract][Full Text] [Related]
6. Acid solution is a suitable medium for introducing QX-314 into nociceptors through TRPV1 channels to produce sensory-specific analgesic effects.
Liu H; Zhang HX; Hou HY; Lu XF; Wei JQ; Wang CG; Zhang LC; Zeng YM; Wu YP; Cao JL
PLoS One; 2011; 6(12):e29395. PubMed ID: 22216270
[TBL] [Abstract][Full Text] [Related]
7. Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review.
Roberson DP; Binshtok AM; Blasl F; Bean BP; Woolf CJ
Br J Pharmacol; 2011 Sep; 164(1):48-58. PubMed ID: 21457220
[TBL] [Abstract][Full Text] [Related]
8. TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells.
Vos MH; Neelands TR; McDonald HA; Choi W; Kroeger PE; Puttfarcken PS; Faltynek CR; Moreland RB; Han P
J Neurochem; 2006 Nov; 99(4):1088-102. PubMed ID: 17018028
[TBL] [Abstract][Full Text] [Related]
9. Selectively targeting pain in the trigeminal system.
Kim HY; Kim K; Li HY; Chung G; Park CK; Kim JS; Jung SJ; Lee MK; Ahn DK; Hwang SJ; Kang Y; Binshtok AM; Bean BP; Woolf CJ; Oh SB
Pain; 2010 Jul; 150(1):29-40. PubMed ID: 20236764
[TBL] [Abstract][Full Text] [Related]
10. Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents.
Binshtok AM; Gerner P; Oh SB; Puopolo M; Suzuki S; Roberson DP; Herbert T; Wang CF; Kim D; Chung G; Mitani AA; Wang GK; Bean BP; Woolf CJ
Anesthesiology; 2009 Jul; 111(1):127-37. PubMed ID: 19512868
[TBL] [Abstract][Full Text] [Related]
11. Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block.
Brenneis C; Kistner K; Puopolo M; Jo S; Roberson D; Sisignano M; Segal D; Cobos EJ; Wainger BJ; Labocha S; Ferreirós N; von Hehn C; Tran J; Geisslinger G; Reeh PW; Bean BP; Woolf CJ
Br J Pharmacol; 2014 Jan; 171(2):438-51. PubMed ID: 24117225
[TBL] [Abstract][Full Text] [Related]
12. Lighting a backfire to quench the blaze: a combined drug approach targeting the vanilloid receptor TRPV1.
Blumberg PM
Mol Interv; 2007 Dec; 7(6):310-2. PubMed ID: 18199852
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping the function of TRPV1-expressing sensory neurons by targeted axonal silencing.
Brenneis C; Kistner K; Puopolo M; Segal D; Roberson D; Sisignano M; Labocha S; Ferreirós N; Strominger A; Cobos EJ; Ghasemlou N; Geisslinger G; Reeh PW; Bean BP; Woolf CJ
J Neurosci; 2013 Jan; 33(1):315-26. PubMed ID: 23283344
[TBL] [Abstract][Full Text] [Related]
14. Expression of TRPV1 channels after nerve injury provides an essential delivery tool for neuropathic pain attenuation.
Zakir HM; Mostafeezur RM; Suzuki A; Hitomi S; Suzuki I; Maeda T; Seo K; Yamada Y; Yamamura K; Lev S; Binshtok AM; Iwata K; Kitagawa J
PLoS One; 2012; 7(9):e44023. PubMed ID: 22962595
[TBL] [Abstract][Full Text] [Related]
15. Quaternary Lidocaine Derivative QX-314 Activates and Permeates Human TRPV1 and TRPA1 to Produce Inhibition of Sodium Channels and Cytotoxicity.
Stueber T; Eberhardt MJ; Hadamitzky C; Jangra A; Schenk S; Dick F; Stoetzer C; Kistner K; Reeh PW; Binshtok AM; Leffler A
Anesthesiology; 2016 May; 124(5):1153-65. PubMed ID: 26859646
[TBL] [Abstract][Full Text] [Related]
16. Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314.
Puopolo M; Binshtok AM; Yao GL; Oh SB; Woolf CJ; Bean BP
J Neurophysiol; 2013 Apr; 109(7):1704-12. PubMed ID: 23303863
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.
Bölcskei K; Tékus V; Dézsi L; Szolcsányi J; Petho G
Eur J Pain; 2010 May; 14(5):480-6. PubMed ID: 19800272
[TBL] [Abstract][Full Text] [Related]
18. QX-314 produces long-lasting local anesthesia modulated by transient receptor potential vanilloid receptors in mice.
Ries CR; Pillai R; Chung CC; Wang JT; MacLeod BA; Schwarz SK
Anesthesiology; 2009 Jul; 111(1):122-6. PubMed ID: 19512885
[TBL] [Abstract][Full Text] [Related]
19. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
[TBL] [Abstract][Full Text] [Related]
20. Fire in the hole: pore dilation of the capsaicin receptor TRPV1.
Bautista D; Julius D
Nat Neurosci; 2008 May; 11(5):528-9. PubMed ID: 18437189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
